Prostate cancer is the second leading cause of cancer death in men in the U.S. But the risks aren't equal. Black men are 50% more likely to be diagnosed with prostate cancer and 2.5 times more likely to die from the disease than are men of Asian, Hispanic, or European descent.
Screening is an important tool for detecting prostate cancer in its early stages, when it's most treatable. Prostate cancer screening involves a simple blood test to measure prostate-specific antigen (PSA) combined with a physicial examination of the prostate.
Prostate cancer screening is recommended for most men starting at age 55. Black men and those with a family history of prostate cancer should discuss with their physician whether they should be screened earlier. Most men are screened every two years, but more frequent screening may be recommended in certain cases.